21/47US=36-F / Biol/Mol
Abbas AK, Lichtman AH, Pillai S. Citocinas. In: ___. Imunologia celular e molecular. 6ª ed. Rio de Janeiro: Elsevier, 2008. p. 267-301. ISBN 85-3522244-9.

CITOCINAS; CATEGORIA DAS CITOCINAS; INTERLEUCINA; FATOR DE CELULA-TRONCO

22/47US=67 / Biol/Mol
Koon HB, Atkins MB. Cytokine-based therapy for cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 471-507. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

CANCER. TERAPIA; CITOQUINA; INTERFERON; INTERLEUCINA; IMUNOTERAPIA; RESISTENCIA; LEUCEMIA DE CELULAS PILOSAS; LEUCEMIA MIELOIDE CRONICA; LINFOMA NAO-HODGKIN; MELANOMA; CARCINOMA DE CELULAS RENAIS; SARCOMA DE KAPOSI

23/47US=8 / Dermatologia
Turner MLC. Cutaneous reactions to cytokines and growth factors. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1347-51. ISBN 978-0-07138076-0.

REACOES CUTANEAS; CITOCINAS; FATORES DE CRESCIMENTO; INTERFERONS; INTERLEUCINA; FATORES DE CRESCIMENTO HEMATOPOETICOS

24/47US=21 / Neurologia
Mason A, Toms S, Hercbergs A. Contemporary investigational treatments: biological modifiers. In: Barnett GH. High-grade gliomas: diagnosis and treatment. New Jersey: Humana Press, 2007. p. 405-17. (Current Clinical Oncology) ISBN 978-1-58829-511-8.

GLIOMA DE ALTO GRAU. TERAPIA; MODIFICADORES BIOLOGICOS; GLIOBLASTOMA; HIPOTIREOIDISMO; TAMOXIFENO; FATORES DE NECROSE TUMORAL; INTERLEUCINA-2; INTERLEUCINA-4; INTERLEUCINA-12; INTERLEUCINA-13; INTERFERON; INTERFERON ALFA; INTERFERON GAMA; INTERFERON BETA; HORMONIO DA TIREOIDE; ESTEROIDES

25/47US=36 / Gastro
McAuliffe PF, Moldawer LL. Endotoxin and cytokines in liver and biliary tract disease. In: Blumgart LH. Surgery of the biliary tract, and pancreas. 4th ed. Philadelphia: Elsevier Saunders, 2007. p. 108-24. (v.1) ISBN 978-1-4160-3256-8.

CITOCINAS NO FIGADO; DOENCA DO TRATO BILIAR; RECONHECIMENTO DE INVASAO MICROBIANA; ENDOTOXINA; FACTOR DE NECROSE TUMORAL DA FAMILIA &*945;; INTERLEUCINA-1; INTERLEUCINA-6; CITOCINAS DO FIGADO

26/47US=33 / Clín/Médica
Emerson F, Mendes KAP, Rios JBM, Carvalho LP. Reações adversas a medicamentos e aditivos (reações adversas a drogas): reações adversas a medicamentos utilizados na prática clínica: reações adversas a medicamentos usados em oncologia. In: Rios JBM, Carvalho LP. Alergia clínica: diagnóstico e tratamento. 2ª ed. Rio de Janeiro: Revinter, 2007. p. 653-63. ISBN 85-3720057-3.

REACOES ADVERSAS A MEDICAMENTOS; PRATICA CLINICA; CANCER; ONCOLOGIA; DROGAS ALQUILANTES; SULFONATOS ALQUILICOS; BUSSULFAM; NITROSOUREIA; CICLOFOSFAMIDA; IFOSFAMIDA; CLORAMBUCIL; MECLORETAMINA; MELFALAN; PRODUTOS NATURAIS ANTINEOPLASICOS; L. ASPARAGINASE; VIMBLASTINA; VINCRISTINA; TAXANE; DOCETAXEL; PACLITAXEL; EPIDOFILOTOXINA; ETOPOSIDA; TENIPOSIDA; CAMPTOTECINA; TOPOTECAN; IRINOTECAN; ANTIBIOTICOS ANTINEOPLASICOS; BLEOMICINA; DACTINOMICINA; ACTINOMICINA D; DAUNORRUBICINA; DOXORRUBICINA; PLICAMICINA; MITRAMICINA; MITOMICINA; IMUNOMODULADORES; INTERFERONS; INTERLEUCINA-2; CICLOSPORINA; TACROLIMUS; AGENTES ANTIPROLIFERATIVOS; SIROLIMUS; ANTICORPOS MONOCLONAIS; ANTICORPOS POLICLONAIS; ANTIMETABOLITOS; METOTREXATO; CITARABINA; FLUOROURACIL; MERCAPTOPURINA; AZATIOPRINA; HORMONIOS; CORTICOSTEROIDES; ESTROGENIOS; ANDROGENIOS; ANTIANDROGENIOS; FLUTAMIDA; NILUTAMIDA; BICALUTAMIDA; ANTIESTROGENIOS; TAMOXIFENO; CLOMIFENO; SUPRESSORES CORTICO-SUPRA-RENAIS; MITOTANO; AMINOGLUTETIMIDA; CISPLATINA; CARBOPLATINA; HIDROXIUREIA

27/47US=93 / Biol/Mol
Lotze MT. Cytokines and carcinogenesis: interleukin-1 family of cytokines and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 113-33. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS; CARCINOGENESE; INTERLEUCINA-1 DA FAMILIA DE CITOQUINAS; CANCER

28/47US=93 / Biol/Mol
Nishimoto N. Cytokines and carcinogenesis: interleukin-6 and Castleman's disease. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 155-63. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS; CARCINOGENESE; INTERLEUCINA-6; DOENCA DE CASTLEMAN

29/47US=93 / Biol/Mol
Fujii SI, Lotze MT. Cytokines and carcinogenesis: interleukin-10 (IL-10). In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 165-79. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS; CARCINOGENESE; INTERLEUCINA-10; IL-10

30/47US=93 / Biol/Mol
Margolin K, Clark J. Cytokines in the treatment of cancer: interleukin-2 and cancer therapy. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 307-16. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS NO TRATAMENTO DE CANCER; INTERLEUCINA-2; TERAPIA DO CANCER

31/47US=93 / Biol/Mol
Bael TE, Gollob JA. Cytokines in the treatment of cancer: interleukin-12 and cancer therapy. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 317-38. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS NO TRATAMENTO DE CANCER; INTERLEUCINA-12; TERAPIA DO CANCER

32/47US=93 / Biol/Mol
Villalona-Calero MA. Cytokines in the treatment of cancer: anticytokine treatment. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 437-48. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS NO TRATAMENTO DE CANCER; TRATAMENTO ANTICITOCINA; FATOR DE NECROSE TUMORAL; INTERLEUCINA 1

33/47US=3 / Ginecologia
Smola-Hess S, Pfister H. Immune evasion in genital papillomavirus infection and cervical cancer: role of cytokines and chemokines. In: Campo MS. Papillomavirus research: from natural history to vaccines and beyong. Wymondham: Caister Academic Press, 2006. p. 321-39. ISBN 1-904455-04-2.

PAPILOMAVIRUS HUMANO; HPV; EVASAO IMUNE; PAPILOMAVIRUS GENITAL; CANCER CERVICAL; CITOCINAS; QUIMIOCINAS; MICROAMBIENTE DA MUCOSA; PROTEINA INFLAMATORIA MACROFAGICA-3ALFA; INTERLEUCINA-10; FATOR DE CRESCIMENTO TRANSFORMADOR-BETA; INTERLEUCINA-6; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; NECROSE TUMORAL-ALFA; TNF-ALFA; CD40

34/47US=45 / Urologia
Brehmer B, Makris A, Jakse G. New serum markers for prostate cancer. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 26-39. ISBN 978-1-4051-0752-9.

CANCER DE PROSTATA; MARCADORES SERICOS; MARCADORES NEUROENDOCRINOS; FATOR DE CRESCIMENTO INSULINICO; CITOCINAS; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; FATOR DE TRANSFORMACAO DO CRESCIMENTO BETA; INTERLEUCINA-6; METALOPROTEINASES DA MATRIZ; PROTEOMICA DE SORO

35/47US=14 / Urologia
McDermott DF, Atkins MB. Kidney cancer: management of mestatatic renal cell carcinoma: interleukin-2. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 773-80. ISBN 978-0-7817-4984-0.

CANCER DE RIM; CARCINOMA DE CELULAS RENAIS MESTATATICO. TERAPIA; INTERLEUCINA-2

36/47US=47 / Clín/Medica
Labbozzetta M, Notarbartolo M, Poma P, Giannitrapani L, Cervello M, Montalto G, D'Alessandro N. Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 268-75. ISBN 978-1-57331-699-5.

CARCINOMA HEPATOCELULAR; INTERLEUCINA-6; CIRCUITO ESTIMULANTE DO CRESCIMENTO CELULAR AUTOCRINE; NF-KB

37/47US=8 / Ortopedia
Iannetta O. Matriz mesenquimal óssea e etiopatogenia da osteoporose no climatério. In: ___. Osteoporose: uma ex-enfermidade silenciosa. Ribeirão Preto: Tecmedd, 2006. p. 62-95. ISBN 85-99276-03-4.

OSTEOPOROSE. ETIOPATOGENIA; MATRIZ MESENQUIMAL OSSEA; CLIMATERIO; FRATURA; TECIDOS CONECTIVOS; VITAMINA D; PTH; CALCITONINA; ESTROGENIO; PROGESTERONA; PROGESTAGENIOS; GLICOCORTICOIDES; CIGARRO; ATIVIDADE FISICA; REMODELACAO OSSEA; OSTEOBLASTOS; OSTEOCLASTOS; FORMACAO OSSEA; TGF; INTERLEUCINA-6; INTERLEUCINA-11

38/47US=8 / Quimioterapia
Petros WP. Hematopoietic growth factors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 747-66. ISBN 978-0-7817-5628-6.

FATORES DE CRESCIMENTO HEMATOPOIETICOS; QUIMICA; FARMACEUTICA; RECEPTORES DO FATOR DE CRESCIMENTO HEMATOPOIETICO; MECANISMOS DE ACAO; EFEITOS BIOLOGICOS; FARMACOLOGIA CLINICA; DADOS CLINICOS DE MEDICAMENTOS INDIVIDUAIS; ERITROPOIETINA; FATOR ESTIMULANTE DE COLONIAS GRANULOCITOS; FATOR ESTIMULANTE DE COLONIAS MACROFAGOS; INTERLEUCINA 11; TROMBOPOIETINA

39/47US=8 / Quimioterapia
Alatrash G, Bukowski RM, Tannenbaum CS, Finke JH. Interleukins. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 767-808. ISBN 978-0-7817-5628-6.

INTERLEUCINA-2; INTERLEUCINA-4; FATOR DE NECROSE TUMORAL; INTERLEUCINA-11; INTERLEUCINA-12

40/47US=21-A / Dermatologia
Kawamura C, Buzaid AC. Interleucina-2 e tratamentos combinados (bioquimioterapia). In: Wainstein AJA, Belfort FA. Melanoma: prevenção, diagnóstico, tratamento e acompanhamento. São Paulo: Atheneu, 2014. p. 301-307. ISBN 978-85-86652-31-0.

MELANOMA METASTATICO. TERAPIA; MELANOMA METASTATICO. BIOQUIMIOTERAPIA; INTERLEUCINA-2 EM ALTAS DOSES

Primeira | Anterior | Próxima | Última